Preadmission beta-blocker use and 30-day mortality among patients in intensive care: a cohort study

INTRODUCTION: Beta-blockers have cardioprotective, metabolic and immunomodulating effects that may be beneficial to patients in intensive care. We examined the association between preadmission beta-blocker use and 30-day mortality following intensive care. METHODS: We identified 8,087 patients over...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Steffen, Johansen, Martin Berg, Tønnesen, Else, Larsson, Anders, Pedersen, Lars, Lemeshow, Stanley, Sørensen, Henrik Toft
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219345/
https://www.ncbi.nlm.nih.gov/pubmed/21385356
http://dx.doi.org/10.1186/cc10085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219345/
https://www.ncbi.nlm.nih.gov/pubmed/21385356
http://dx.doi.org/10.1186/cc10085

Ejemplares similares